文献速递糖尿病

RFX6缺失损害iPSC来源的胰岛类器官发育与存活,但不影响PDX1+/NKX6.1+祖细胞

Deletion of RFX6 impairs iPSC-derived islet organoid development and survival, with no impact on PDX1+/NKX6.1+ progenitors.
PubMed 文献 · Diabetologia · 2024-07-30

研究探讨RFX6功能缺失导致胰腺发育不良和胰岛形成受损的机制。利用CRISPR/Cas9构建RFX6缺失的iPSC,发现RFX6缺失不影响PDX1+/NKX6.1+胰腺祖细胞,但导致内分泌分化基因下调、细胞凋亡增加、胰岛类器官变小,过表达RFX6可逆转缺陷表型。

要点

  • RFX6缺失不影响PDX1+/NKX6.1+胰腺祖细胞的形成。
  • RFX6缺失导致胰腺内分泌分化、胰岛素分泌和离子转运相关基因下调。
  • RFX6缺失通过增加细胞凋亡导致胰岛类器官变小,与过氧化氢酶表达降低相关。

核心结论

  • RFX6突变相关的胰腺发育不良和胰岛细胞形成减少并非由于PDX1+/NKX6.1+胰腺祖细胞改变,而是源于细胞凋亡和胰腺内分泌基因下调。

研究设计与样本

  • 利用人胚胎干细胞(hESC)向胰岛分化的体系检测RFX6表达,并重新分析单细胞RNA-seq数据集。
  • 使用CRISPR/Cas9构建RFX6缺失的诱导多能干细胞(iPSC)系,在多个发育阶段探究RFX6缺失的后果。
  • 对胰腺祖细胞(PPs)和内分泌祖细胞(EPs)进行RNA-seq分析RFX6缺失引起的转录变化。

主要发现

  • RFX6在hESC来源的后前肠(PF)PDX1+细胞中表达,但在PPs中不与PDX1或NKX6.1共定位,而与神经元素3、NK2同源盒2及胰岛激素在EPs和胰岛中共定位。
  • 单细胞分析显示RFX6在hESC来源的胰腺分化各阶段的内分泌细胞簇中高表达。
  • RFX6缺失的iPSC分化为胰岛时,PF阶段PDX1表达显著降低,但不影响共表达PDX1和NKX6.1的PPs。
  • RNA-seq显示RFX6缺失导致胰腺内分泌分化、胰岛素分泌和离子转运相关关键基因下调。
  • RFX6缺失因细胞凋亡增加导致胰岛类器官变小,与过氧化氢酶表达降低相关,过表达RFX6可逆转RFX6敲除的PPs、EPs和胰岛的缺陷表型。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Homozygous mutations in RFX6 lead to neonatal diabetes accompanied by a hypoplastic pancreas, whereas heterozygous mutations cause MODY. Recent studies have also shown RFX6 variants to be linked with type 2 diabetes. Despite RFX6's known function in islet development, its specific role in diabetes pathogenesis remains unclear. Here, we aimed to understand the mechanisms underlying the impairment of pancreatic islet development and subsequent hypoplasia due to loss-of-function mutations in RFX6. METHODS: We examined regulatory factor X6 (RFX6) expression during human embryonic stem cell (hESC) differentiation into pancreatic islets and re-analysed a single-cell RNA-seq dataset to identify RFX6-specific cell populations during islet development. Furthermore, induced pluripotent stem cell (iPSC) lines lacking RFX6 were generated using CRISPR/Cas9. Various approaches were then employed to explore the consequences of RFX6 loss across different developmental stages. Subsequently, we evaluated transcriptional changes resulting from RFX6 loss through RNA-seq of pancreatic progenitors (PPs) and endocrine progenitors (EPs). RESULTS: RFX6 expression was detected in PDX1+ cells in the hESC-derived posterior foregut (PF). However, in the PPs, RFX6 did not co-localise with pancreatic and duodenal homeobox 1 (PDX1) or NK homeobox 1 (NKX6.1) but instead co-localised with neurogenin 3, NK2 homeobox 2 and islet hormones in the EPs and islets. Single-cell analysis revealed high RFX6 expression levels in endocrine clusters across various hESC-derived pancreatic differentiation stages. Upon differentiating iPSCs lacking RFX6 into pancreatic islets, a significant decrease in PDX1 expression at the PF stage was observed, although this did not affect PPs co-expressing PDX1 and NKX6.1. RNA-seq analysis showed the downregulation of essential genes involved in pancreatic endocrine differentiation, insulin secretion and ion transport due to RFX6 deficiency. Furthermore, RFX6 deficiency resulted in the formation of smaller islet organoids due to increased cellular apoptosis, linked to reduced catalase expression, implying a protective role for RFX6. Overexpression of RFX6 reversed defective phenotypes in RFX6-knockout PPs, EPs and islets. CONCLUSIONS/INTERPRETATION: These findings suggest that pancreatic hypoplasia and reduced islet cell formation associated with RFX6 mutations are not due to alterations in PDX1+/NKX6.1+ PPs but instead result from cellular apoptosis and downregulation of pancreatic endocrine genes. DATA AVAILABILITY: RNA-seq datasets have been deposited in the Zenodo repository with accession link (DOI: https://doi.org/10.5281/zenodo.10656891 ).

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Aldous N, Elsayed AK, Memon B, et al. Deletion of RFX6 impairs iPSC-derived islet organoid development and survival, with no impact on PDX1+/NKX6.1+ progenitors. Diabetologia. 2024. PMID: 39080045. doi:10.1007/s00125-024-06232-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。